Indice
Descrizione indicatore
L’indicatore ci consente di calcolare la percentuale di pazienti colpiti da infarto miocardico acuto (IMA) con sopraslivellamento del tratto ST (STEMI) che vengono sottoposti ad angioplastica (PTCA) entro 90 minuti dall'accesso in ospedale, rispetto al totale dei pazienti ricoverati per IMA STEMI.
Come si legge
L’indicatore si riferisce al grado di “
appropriatezza" delle cure prestate.
Più alto è il numero di pazienti sottoposti ad angioplastica (PTCA) entro 90 minuti dall'accesso in ospedale, maggiore è l'appropriatezza nel curare tempestivamente i pazienti colpiti da IMA STEMI.
Fonte del dato
Programma Nazionale Esiti 2023.
Confronto tra strutture calcolato su dati 2022.
Valutazione istituzionale
Il Ministero della salute ha stabilito che la percentuale di pazienti che ogni anno effettua un intervento chirurgico di PTCA
entro 90 minuti dall’ingresso in ospedale dovrebbe essere
almeno del
60% rispetto al totale dei ricoveri per infarto miocardico acuto con sopraslivellamento del tratto ST (STEMI).
Il semaforo è calcolato sulla base dei seguenti documenti ufficiali:
Consulta le strutture sanitarie che effettuano in un anno il maggior numero di ricoveri per infarto miocardico acuto Approfondisci anche gli altri indicatori relativi a:
Altre informazioni
Codici ICD-9-CM selezionati
L’esito è l’esecuzione della PTCA entro 90 minuti dall'ingresso in ospedale dall'ora di ricovero o di accesso in Pronto Soccorso (codici ICD-9-CM in qualsiasi campo di procedura: 00.66, 36.01, 36.02, 36.05, 36.06 36.07). Viene attribuito alla struttura in cui è avvenuto il ricovero indice.
L’analisi è effettuata su base annuale.
Criteri di eleggibilità
Tutti i ricoveri, in regime ordinario, con diagnosi principale di IMA (ICD-9-CM 410.xx) o con diagnosi principale di una condizione compatibile con la diagnosi di infarto ed IMA in secondaria.
Le diagnosi principali compatibili con la diagnosi di infarto, comprese complicanze legate a procedura, sono:
- 411: Altre forme acute e subacute di cardiopatia ischemica
- 413: Angina pectoris
- 414: Altre forme di cardiopatia ischemica cronica
- 423.0: Emopericardio
- 426: Disturbi della conduzione
- 427 (escluso 427.5): Aritmie cardiache
- 428: Scompenso cardiaco
- 429.5: Rottura di corda tendinea
- 429.6: Rottura di muscolo papillare
- 429.71: Difetto settale acquisito
- 429.79: Altri postumi di IMA non classificati altrove (Trombo murale acquisito)
- 429.81: Altre alterazioni del muscolo papillare
- 518.4: Edema polmonare acuto, non specificato
- 518.81: Insufficienza respiratoria acuta
- 780.01: Coma
- 780.2: Sincope e collasso
- 785.51: Shock cardiogeno
- 799.1: Collasso respiratorio
- 997.02: Infarto o emorragia cerebrovascolare iatrogena (stroke postoperatorio)
- 998.2: Perforazione accidentale da catetere
Criteri di esclusione
- Ricoveri di pazienti non residenti in Italia;
- Ricoveri di pazienti di età inferiore ai 18 e superiore ai 100 anni;
- Ricoveri con degenza inferiore alle 48 ore e dimissione a domicilio o contro il parere del medico;
- Ricoveri preceduti, nelle 4 settimane precedenti, da un ricovero con diagnosi di IMA;
- Episodi di infarto miocardico acuto in cui compaia un codice ICD-9-CM di diagnosi 410.7X (infarto subendocardico) o 410.9.X (infarto a sede non specificata) in almeno un ricovero dell’episodio.
Fonti scientifiche
- Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003; 349(8): 733-42.
- Antman EM, Anbe DT, Armstrong PW et al; ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2004;44(3):E1-E211
- Berger PB, Ellis SG, Holmes DR Jr et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999; 100 (1): 14-20.
- Busk M, Maeng M, Kristensen SD et al. Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial. Am J Cardiol. 2009 Jul 15;104(2):210-5.
- Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
- Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med. 2000;342 (21):1573–1580.
- Cantor WJ, Fitchett D, Borgundvaag B et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009 Jun 25;360(26):2705-18.
- Cotoni DA, Roe MT, Li S et al. Frequency of Nonsystem Delays in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention and Implications for Door-to-Balloon Time Reporting (from the American Heart Association Mission: Lifeline Program). Am J Cardiol. 2014 Apr 16.
- Dalby M, Kharbanda R, Ghimire G et al. Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. Am Heart J. 2009 Nov;158(5):829-35.
- Davoli M, Amato L, Minozzi S, Bargagli AM, Vecchi S, Perucci CA. Volume di attività ed esito delle cure: revisione sistematica della letteratura. Epidemiol Prev. 2005; 29(3-4 Suppl):3- 63.
- De Luca G., Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Archives of Internal Medicine. 2012; 172(8):611-621.
- Dehmer GJ, Blankenship JC, Cilingiroglu M et al. SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without On-Site Surgical Backup. Circulation. 2014 Mar 17.
- European Society of Cardiology. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24, 28-66.
- Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. Is the Slope of the Curve the Shape of the Future? JAMA 2005;293:979-986.
- Grines CL, Westerhausen DR Jr, Grines LL et al.; Air PAMI Study Group. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol. 2002; 39(11):1713-9.
- Gruppo di lavoro del Programma Nazionale Esiti. Amato L, Fusco D, Acampora A, Bontempi K, Rosa AC, Colais P, Cruciani F, D’Ovidio M, Mataloni F, Minozzi S, Mitrova Z, Pinnarelli L, Saulle R, Soldati S, Sorge C, Vecchi S, Ventura M, Davoli M. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data. Epidemiol Prev. 2017 Sep-Dec;41(5-6 Suppl 2):1-128. doi: 10.19191/EP17.5-6S2.P001.100.
- Hochman JS, Reynolds HR, Dzavik V, Buller CE, Ruzyllo W, Sadowski ZP et al. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. Circulation. 2011; 124(21):2320-2328.
- Huynh T, Perron S, O'Loughlin J et al. Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies. Circulation. 2009 Jun 23;119(24):3101-9.
- Juliard JM, Feldman LJ, Golmard JL et al. Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. Am J Cardiol. 2003 15;91(12):1401-5.
- Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
- Kumbhani DJ, Cannon CP, Fonarow GC et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009 Nov 25;302(20):2207-13.
- Longenecker JC, Alfaddagh A, Zubaid M et al. Adherence to ACC/AHA performance measures for myocardial infarction in six Middle-Eastern countries: association with in-hospital mortality and clinical characteristics. Int J Cardiol. 2013 Aug 20;167(4):1406-11. doi: 10.1016/j.ijcard.2012.04.066. Epub 2012 May 10.
- New York State Department of Health. Percutaneous coronary intervention (PCI) in New York State 2003-2005. Albany, New York: New York State Department of Health; 2008. Disponibile al sito: http://www.health.state.ny.us/statistics/diseases/cardiovascular/
- Nordmann AJ, Bucher H, Hengstler P, Harr T, Young J. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction [Review]. Cochrane Database of Systematic Reviews 2008, Issue 4.
- Parma A, Fiorilli R, Nazzaro MS et al. Primary coronary angioplasty in ST-elevation myocardial infarction: prediction of the thirty-day mortality risk in an unselected population of patients. Ital Heart J 2004; 5 (6): 431-440.
- Pipilis A, Andrikopoulos G, Lekakis J, Kalantzi K, Kitsiou A, Toli K et al.; on behalf of the HELIOS group. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry. Eur J Cardiovasc Prev Rehabil 2009.
- Rogers WJ, Canto JG, Barron HV, Boscarino JA, Shoultz DA, Every NR. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the national registry of myocardial infarction. J Am Coll Cardiol 2000;35:371-9.
- Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Assoc Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 guidelines for PCI). Circulation 2006;113;156-175
- Srinivas VS, Hailpern SM, Koss E et al. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol. 2009 Feb 17;53(7):574-9.
- Tarantini G, Razzolini R, Napodano M et al. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. Eur Heart J. 2010 Mar;31(6):676-83. Epub 2009 Nov 27.
- Van de Werf F, Gore JM, Avezum A, Gulba DC, Goodman SG, Budaj A, et al; GRACE Investigators. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ 2005;330(7489):441.
- Vivian Ho. Evolution of the Volume-Outcome Relation for Hospitals Performing Coronary Angioplasty. Circulation. 2000;101:1806-1811.
- Widimsky P, Budesinsky T, Vorac D et al.; 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J. 2003;24(1):94-104.
